Myxredlin Injection, Solution
Product Images NDC 0338-0126

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Myxredlin (NDC 0338-0126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Insulin Human (Image 01)

Chemical structure diagram of insulin human showing the amino acid sequence and disulfide bonds between A-chain and B-chain residues, with each amino acid labeled and cysteine residues highlighted.*

FDA Label Image

Representative Container Lbl 0338-0126-12 (Image 02)

MYXREDLIN Insulin Human 1 unit/mL injection solution in 0.9% Sodium Chloride, displayed on a label for a 100 mL single-dose GALAXY container. The label indicates it is for intravenous infusion only, sterile, nonpyrogenic, regular insulin human. Manufacturer is Baxter Healthcare Corporation.*

FDA Label Image

Representative Carton Label 0338-0126-12 (Image 03)

Packaging label of MYXREDLIN injection, solution containing insulin human 1 IU/mL. The label includes a prominent red section with the text 'CONTAINS INSULIN' in white, upside down. There is a barcode section with the numeric code 0338380126125 and a note stating 'BAR CODE POSITION ONLY UPC-A'. The labeler is Baxter Healthcare Corporation.*

FDA Label Image

Representative Serialzied Shipper Label (Image 04)

Packaging label for MYXREDLIN Insulin Human injection, 1 unit/mL strength in 0.9% Sodium Chloride Injection. This product is for intravenous infusion only, containing 100 units per 100 mL. The label shows it is a single-dose GALAXY container, Rx only, manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Image 05

Label for MYXREDLIN insulin human injection, 100 units per 100 mL (1 unit/mL) in 0.9% sodium chloride solution. The label indicates this is a single-dose product packaged in 12 x 100 mL containers. It is labeled for intravenous use and produced by Baxter Healthcare Corporation. Storage instructions specify refrigeration at 2°C to 8°C and caution to not freeze or shake, with additional room temperature storage guidelines.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.